Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis

Autor: Sandborn, William J., Regula, Jaroslaw, Feagan, Brian G., Belousova, Elena, Jojic, Njegica, Lukas, Milan, Yacyshyn, Bruce, Krzeski, Piotr, Yeh, Chyon–Hwa, Messer, Christi A., Hanauer, Stephen B.
Zdroj: In Gastroenterology December 2009 137(6):1934-1943
Databáze: ScienceDirect